A vaccine factory in China has qualified to mass produce a COVID-19 vaccine.
In a press release on Wednesday, China National Biotec Group said that in mid-July its world's first inactivated COVID-19 vaccine production plant in Beijing passed joint biosafety inspections organized by relevant departments, and is qualified to put a vaccine into mass production at any time.
Previously, the production facility had obtained a COVID-19 vaccine production license.
China National Biotec Group claims that this high-level biosafety production facility is currently the world's first, and the largest production plant for COVID-19 inactivated vaccines.
From design to construction, the workshop follows the relevant biosafety regulations and standards of China and the World Health Organization, and introduces experienced design teams from China and abroad. From building to maintaining, the production is in accordance with the high-level biosafety protection standard. The construction of the plant took only 2 months, and the construction was completed on April 15, 2020.
The construction of the high-level biosafety facilities and supporting laboratory complex of the Wuhan Institute of Biological Products of China National Biotech was completed on July 1. It strives to obtain relevant inspections and have production conditions as soon as possible.
The company says that China Biotech Group-Wuhan Institute of Biological Products will also become the world's only biological product R&D and production unit with a high-level biosafety R&D laboratory and production facility complex.
After the production plants of the two research institutes in Beijing and Wuhan are put into use, they will be able to guarantee that the annual production capacity of the COVID-19 inactivated vaccine will reach 220 million doses.
- Global COVID-19 cases surpass 600 mln: WHO
- Regulator expands use of HPV vaccine
- China’s first domestic HPV vaccine shows 100 pct efficacy in clinical trial
- China’s vaccine regulatory system passes latest WHO assessment
- U.S. first lady tests positive for COVID-19
- China’s home-produced Omicron-specific mRNA vaccine to start trials
Popular Videos
Hot comments
- First apes at U.S. zoo receive COVID-19 vaccine made for animals, zoo official says
- China Life: Chinese women shine with She Power
- Foreign firms approved to offer VPN services in capital
- Homemade curling videos trending in China
- 86-year-old grandma in Hebei spends most her life on traditional cheongsam
- Winners of 2022 Inaugural WLA Prize announced
- Lantern Festival: A romantic celebration in China
- Two Chinese COVID-19 vaccine firms to supply vaccines to COVAX
- Media center for 20th CPC national congress to open on Oct. 12
- Six suspects arrested in HK for role in SE Asia job scam
Top Reviews
- Young artists recreate beauty of traditional Hanfu costume
- China releases photos of tallest tree
- English version of ‘Understanding Xi Jinping’s Educational Philosophy’ published
- China crowned in men’s team for 10th straight time at table tennis worlds
- China publishes Atlas of Wildlife in SW China
- Guangxi’s 10 Years: A Visit to China’s Qinzhou Port
- Congress delegate helped lift village out of poverty
- Expo highlights joint efforts in NEV development
- Racism stain of shame on ‘world democratic paradise’
- U.S. may face new COVID wave this upcoming winter: report